SWAG视频

Management Development Program, Harvard Graduate School of Education (HGSE), June 2023

Academic Leadership Certification, Haas School of Business, University of California, Berkeley, 2012

AACP Fellow, Academic Leaders Fellowship Program (ALFP), 2009

Doctor of Philosophy (PhD), Pharmaceutics, 1996
West Virginia University, Morgantown, WV

Bachelor of Pharmacy (B.Pharm)1987
Birla Institute of Technology, India

Formulation development of novel drug delivery systems; application of nanotechnology
for controlled release system design; cancer chemoprevention; targeted therapy.

Principal Investigator, 鈥淐ombinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention鈥� NIH, National Cancer Institute (NCI), R15 program, 2014-2017.

Principal Investigator, 鈥淐hemoprevention of pancreatic cancer using a combinatorial nano-drug system鈥� NIH, National Cancer Institute (NCI), R03 program, 2011-2013.

Principal Investigator, "Combined Chemoprevention Using A Nanotechnology-based Therapeutic System", NIH, National Cancer Institute (NCI), R03 Program, 2007- 2010.

Thakkar A, Chenreddy S, Wang J, Prabhu S. 鈥淓valuation of Ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention鈥� Int J. Onc., accepted, January 2015.

L. Luo, J. Lacroix, S. Prabhu, 鈥淎ntibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer." Case Studies: Ado-Trastuzumab Emtansine. AAPS-Springer, In press, January 2015.

Liu M, Ravula R, Wang Z, Zuo Z, Chow M, Thakkar A, Prabhu S, Andresen B, Huang Y. 鈥淭raditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.鈥� Cell & Bioscience. 2014; 4(1):8. PubMed PMID: doi:10.1186/2045-3701-4-8.

Grandhi BK, Thakkar A, Wang J, Prabhu S. 鈥淎 novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions鈥� Cancer Prev Res., 6 (10), 1015 鈥� 1025, 2013.

A. Thakkar, D. Sutaria, B.K. Grandhi, J. Wang, S. Prabhu, 鈥淭he molecular mechanisms of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer鈥� Onc. Reports, 29, 4, 1671-1677, 2013.

D. Sutaria, B. K. Grandhi, A. Thakkar, J. Wang and S. Prabhu, 鈥淐hemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane (ACS) drug combination regimen鈥�, 41(6):2260 鈥� 2268, Int J Onc, 2012.

A. Chaudhary, D. Sutaria, Ying Huang, J. Wang and S. Prabhu. 鈥淐hemoprevention of Colon Cancer in a Rat Carcinogenesis Model using a Novel Nanotechnology-based Combined Treatment System鈥�. Cancer Prev. Res., 4(10), 1655-1664, 2011.

Prabhu S, Y Huang, Wang J. Evidence-based materia medica for cancer chemoprevention. In: Evidence-based Anticancer Complementary and Alternative Medicine2: Materia Medica for Various Cancers. Cho WCS (Ed), Springer, 2011, 315-351.

C. Ma, S. Prabhu, 鈥淐haracterization of a novel lyophilized chitosan hydrogel complex for the controlled release of a highly water soluble drug, niacinamide.鈥� Int. J. Drug Del. 3 (1):55-63, 2011.